Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine

Editat de Andrew J. Krentz, Robert J. Chilton
Notă GoodReads:
en Limba Engleză Paperback – 28 Mar 2023

Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine discusses the close intersection between metabolic disorders and cardiovascular disease, covering the basic science and pathophysiology of disease and the latest research in pharmacological approaches and translational therapeutic options. This book is a valuable resource for the vascular and endocrinology clinical and research communities in need of knowledge and potential outcomes.

The global increase in the prevalence of cardiometabolic disorders, and the introduction of therapeutic options for treating metabolic disease that also lower cardiovascular risk, is bringing endocrinologists and cardiologists together in a shared clinical experience.

  • Discusses the intersection between metabolic disorders and cardiovascular diseases
  • Provides a comprehensive understanding of the relevant pathophysiology of diseases as a basis for the evidence-based management of cardiometabolic disorders
  • Offers a comprehensive reference, ranging from basic science and pathophysiology to clinical diagnostics and management




Citește tot Restrânge

Preț: 83154 lei

Preț vechi: 87530 lei

Puncte Express: 1247

Preț estimativ în valută:
15962 17070$ 13759£

Carte disponibilă

Livrare economică 27 iunie-11 iulie
Livrare express 17-27 iunie pentru 7499 lei

Preluare comenzi: 021 569.72.76


ISBN-13: 9780323999915
ISBN-10: 0323999913
Pagini: 530
Ilustrații: 100 illustrations (50 in full color)
Dimensiuni: 191 x 235 mm
Greutate: 1.11 kg

Public țintă

Basic scientists working in translational endocrinology or cardiology, practicing endocrinologists and cardiologists.


Part 1. Basic science and pathophysiology
1. Obesity and insulin resistance
2. Diabetes and macrovascular disease: epidemiology and cardiovascular risk assessment
3. Hypertension
4. Lipid metabolism: role in atherogenesis
5. Renal disease and cardiorenal interactions
6. NAFLD/NASH and cardiovascular risk
7. Heart failure
8. Prothrombosis: association with cardiometabolic disease
9. Inflammation, metabolism and cardiovascular disease
10. Classic endocrine disorders: association with vascular disease

Part 2. Clinical evaluation, lifestyle measures and therapeutic options
11. Non-pharmacological strategies in the prevention and management of cardiometabolic disease
12. Obesity: pharmacological approaches to prevention and management
13. Diabetes: evolution of multifactorial vascular risk reduction
14. Diabetes CVOTS: design, interpretation and future directions
15. Novel glucose-lowering drugs: a new era of cardioprotection and renoprotection
16: Hypertension: pharmacological and surgical management
17. PCSK-9 inhibitors and other novel lipid-modifying drugs
18. Recent therapeutic developments in heart failure
19. Antiplatelet agents
20. Progress in anticoagulant therapy
21. Invasive treatment of atherosclerotic cardiovascular disease: today and tomorrow
22. Cardiometabolic medicine in practice: role of cardiologists vs endocrinologists and the need for a new clinical specialty